Sort   by:  
 Page size 
UnknownColombian surgical outcomes study insights on perioperative mortality rate, a main indicator of the lancet commission on global surgery - a prospective cohort study.
Not available
S-EPMC11382124 | biostudies-literature
UnknownUNIversity students' LIFEstyle behaviours and Mental health cohort (UNILIFE-M): study protocol of a multicentre, prospective cohort study.
Not available
S-EPMC12815070 | biostudies-literature
UnknownA Circulating Signature of Tumour Hybrid Cells and Immune Checkpoints Predicts Metastatic Progression in Lung Cancer
Not available
S-EPMC12940895 | biostudies-literature
MetabolomicsComparative Metabolomic Sampling of Upper and Lower Airways by Four Different Methods to Identify Biochemicals That May Support Bacterial Growth
Bacteria need nutrients from the host environment to survive, yet we know little about which biochemicals are present in the airways (the metabolome), which of these biochemicals are essential for bacterial growth and how they change with airway disease. The aims of this pilot study were to develop ...
2019-06-13 | MTBLS179 | MetaboLights
UnknownLong-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Not available
S-EPMC3596060 | biostudies-literature
GenomicsGenetic landscape of inherited retinal dystrophies affected cases in Spain
Inherited retinal diseases (IRDs), defined by dysfunction or progressive loss of photoreceptors, are disorders characterized by elevated heterogeneity, both at the clinical and genetic levels. Our main goal was to address the genetic landscape of IRD in a Spanish cohort of patients. A retrospective ...
EGAS00001005104 | EGA
UnknownEcological niche modelling for predicting the risk of cutaneous leishmaniasis in the Neotropical moist forest biome.
Not available
S-EPMC6693739 | biostudies-literature
ProteomicsProteome expression changes upon Halofuginone treatment
NHCF-V primary cardiac fibroblasts where treated for 24 hours with either 1) 100nM Halofuginone (TMT labels 126 and 129L) 2) 300nM Halofuginone (TMT labels 127L and 129H) 3) 300 nM Halofuginone + 4 mM L-Pro (TMT labels 127H and 130L) 4) DMSO (TMT labels 128H and 131)
ORGANISM(S): Homo sapiens (Human) 
2017-05-16 | PXD005679 | Pride
Primary cardiac fibroblasts Human Halofuginone 
Genomics58747723-e185-4df8-aac6-8e65d2b0f0d3 - samples
In the context of research, this dataset contains 423 IRD samples; 411 of them analyzed with Clinical Exome Sequencing solutions, and 12 with Whole Exome Sequencing.
EGAD00001007022 | EGA
GenomicsIIS - Fundacion Jimenez Diaz Data Access Committee
Data Access Committee EGAC00001002010
EGAC00001002010 | EGA
Sort   by:  
 Page size